Menu
/REGISTER
PPB
Montecito
Nixon Peabody
SBCC
Loading...
You are here:  Home  >  Health Care  -  Page 40
Latest

Amgen funds STEM program for Girl Scouts

By   /  Friday, February 3rd, 2017  /  Education, Health Care, Latest news, Nonprofits  /  Comments Off on Amgen funds STEM program for Girl Scouts

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen beats analyst estimates for fourth quarter revenue

By   /  Thursday, February 2nd, 2017  /  Earnings, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen beats analyst estimates for fourth quarter revenue

Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →

Read More →
Latest

Agilent cancer treatment approved in Europe

By   /  Thursday, February 2nd, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Agilent cancer treatment approved in Europe

Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →

Read More →
Latest

CompuVision, Sagewood announce consolidation

By   /  Tuesday, January 31st, 2017  /  Health Care, Latest news, Technology  /  Comments Off on CompuVision, Sagewood announce consolidation

IT services company CompuVision announced a partnership with health care technology services company Sagewood Systems, both based in Santa Barbara, on Jan. 31. The move will consolidate the companies’ technology, management and communications offerings under the CompuVision brand, it said in a news release, including consulting, enterprise applications and a “hyperconverged infrastructure” system that combines Read More →

Read More →
Latest

Amgen CEO meets with Trump, vows to add 1,600 jobs

By   /  Tuesday, January 31st, 2017  /  Health Care, Latest news  /  Comments Off on Amgen CEO meets with Trump, vows to add 1,600 jobs

Amgen CEO Robert Bradway met with President Donald Trump on Jan. 31 and vowed to add 1,600 jobs, Bloomberg News reported. Trump told biotech leaders at a White House meeting that drug prices needed to come down and he would find a way to streamline the regulatory process. He has discussed having the government negotiate Read More →

Read More →
Latest

InTouch Health to celebrate opening of Goleta headquarters

By   /  Friday, January 27th, 2017  /  Health Care, Latest news  /  Comments Off on InTouch Health to celebrate opening of Goleta headquarters

Telehealth developer InTouch Health will celebrate the grand opening of its new corporate headquarters at 7402 Hollister Ave. in Goleta on Jan. 31. The new facility includes an advanced technology “innovation center” that showcases medical care delivery solutions via robotics and cloud-based networks. InTouch created the world’s first robotic telehealth system shortly after its founding Read More →

Read More →
Latest

Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

By   /  Friday, January 27th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

The European Medicines Agency recommended the approval of the ABP 501, a biosimilar of AbbVie’s Humira (adalimumab), for treatment of inflammatory diseases, Thousand Oaks-based biotech company Amgen announced on Jan. 27. The EMA recommended ABP 501’s use for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate-to-severe Read More →

Read More →